News and Comments

INCYTE: SHOWS ITS PATH TOWARDS GROWTH

  Wednesday, February 12, 2014

 More...

HALOZYME: FINANCING PEGPH20 IS WORTH RAISING MONEY

  Wednesday, February 05, 2014

Halozyme Therapeutics (HALO) stock has been a loser yesterday while other biotech firms have rebounded after dipping during the few days’ of an angry market. The reason for the stock decline was the announcement of pricing of Halozyme’s previously announced underwritten public offering of 7,692,307 shares of its common stock at a public offering price of $13.00 per share.  More...


Recent Postings


Archive


Tags

C4 Therapeutics Sanofi-Aventis (SAN) GlaxoSmithKline (GSK) Multiple Myeloma Human Genome Sciences (HGSI) Sangamo (SGMO) Sanofi (SNY) Incyte (INCY) Biogen Idec (BIIB) Xoma (XOMA) galapagos (GLPG) SUNESIS PHARMACEUTICALS (SNSS) Agenus (AGEN Herceptin GUARDIAN HEALTH Galena (GALE) Trastuzumab-DM1 NEKTAR (NKTR)) ARGOS (ARGS) KITE (KITE) Anacor (ANAC) PTC Therapeutics (PTCT) Velcade (bortezomib) Rapamune Anadys (ANDS) Cytokinetics (CYTK) ACADIA (ACAD) Agenus (AGEN) Pluristem (PSTI) TOKAI (TKAOI) ABBVIE (ABBV) ImmunoGen (IMGN) Endometrial Cancer Roche (ROCHE) Valeant Pharmaceuticals International (VRX) Ionis (IONS) ARCA (ABIO) Abbott Laboratories (ABT) Human Longevity (HLI) INNOVIVA (INVA) Aimmune Therapeutics (AIMT) Bellicum (BLCM) Dendreon (DNDN) Intrexon (XON) Merck (MRK) BIOMARIN (BMRN) CRISPR Therapeutics (CRSP) Adaptimmune (ADAP) AstraZeneca (AZN) Idenix (IDIX) Amgen (AMGN) Vertex (VRTX) Advaxis (ADXS) AGOS (ARGS) Intercept (ICPT) Prosensa (RNA) Spike Therapeutics (ONCE) JUNO (JUNO) CompuGen (CGEN) CEMPRA (CEMP) Zerenex Biocryst (BCRX) Array Pharmaceuticals (ARRY) AERIE PHARMACEUTICALS IDERA (IDRA) Ariad (ARIA) Alnylam (ALNY) Onyx (ONXX) Micromet (MITI) Exelixis (EXEL) Global Cell Therapeutics (GBT) REGULUS (RGLS) Dynavax (DVAX) Roche (RHHBY) ADVENTRIX (ANX) MODERNA Telaprevir Sanofi (SNA) Inovio (INO) SYNTA (SNTA) Ziofpharm (ZIOP) Jazz Pharmaceuticals (JAZZ) Tysabri Genentech ISIS (ISIS) Ocular Therapeutix (OCUL) Sarepta (SRPT) Bristol-Myers Squibb (BMY) Editas (EDIT) Illumina (ILMN) OSI (OSIP) Revlimid (lenolidamide) ZALTRAP™ Ridaforolimus RenenxBio (RGNX) SERES THERAPEUTICS (MCRB) Prolor Biotech (PBTH) Mirati Therapeutics (MRTX) KERYX (KERX) Theravance (THRX) NANTKWEST (NK) NOVOCURE (NVCR) HALOZYME (HALO) Seattle Genetics (SGEN) Theravance Bio Pharma (TBPH) Intermune (ITMN) Alder Biopharmaceuticals (ALDR) Vitae Pharmaceuticals (VTAE) VANDA (VNDA) Sequenom (SQNM) Elan (ELN) Benlysta (belimumab) Gilead (GILD) Auspex (ASPX) Regeneron (REGN)